Bionomics logo

Bionomics share price today

(BNOX)

Bionomics share price is $0.24 & ₹20.39 as on 21 Dec 2024, 2.30 'hrs' IST

$0.24

-0.01

(-2.88%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Bionomics share price in Dollar and Rupees. Guide to invest in Bionomics from India. Also see the sentimental analysis on Indian investors investing in Bionomics. Get details on the Indian mutual funds that are investing in Bionomics. Get Analyst recommendations and forecasts along with all the Bionomics's financials.

Bionomics share price movements

  • Today's Low: $0.23
    Today's High: $0.27

    Day's Volatility :13.4%

  • 52 Weeks Low: $0.18
    52 Weeks High: $1.60

    52 Weeks Volatility :88.94%

Bionomics Returns

PeriodBionomics LtdIndex (Russel 2000)
3 Months
-59.48%
0.0%
6 Months
-67.84%
0.0%
1 Year
-80.91%
0.0%
3 Years
-97.98%
-17.3%

Bionomics Key Statistics

in dollars & INR

Previous Close
$0.2501
Open
$0.251
Today's High
$0.2664
Today's Low
$0.2307
Market Capitalization
$5.1M
Today's Volume
$450.6K
52 Week High
$1.6
52 Week Low
$0.176999
Revenue TTM
$662.0K
EBITDA
$-17.4M
Earnings Per Share (EPS)
$-1.19
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-78.44%

How to invest in Bionomics from India?

It is very easy for Indian residents to invest directly in Bionomics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bionomics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bionomics or BNOX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bionomics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bionomics shares which would translate to 3.541 fractional shares of Bionomics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Bionomics, in just a few clicks!

Returns in Bionomics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bionomics investment value today

Current value as on today

₹1,83,775

Returns

₹83,775

(+83.77%)

Returns from Bionomics Stock

₹81,679 (false-81.68%)

Dollar Returns

₹2,095 (+2.1%)

Indian investors sentiment towards Bionomics

-57%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Bionomics on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -57% less investors are searching Bionomics in the last 30 days versus the previous period.

Global Institutional Holdings in Bionomics

  • Armistice Capital, LLC

    8.16%

  • Point72 Asset Management, L.P.

    1.62%

  • Susquehanna International Group, LLP

    0.17%

  • Rhumbline Advisers

    0.04%

Analyst Recommendation on Bionomics

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Bionomics(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Bionomics

What analysts predicted

Upside of 3894.71%

Current:

$0.24

Target:

$9.59

Insights on Bionomics

  • Price Movement

    In the last 7 days, BNOX stock has moved down by -22.6%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 172.75K → 98.93K (in $), with an average decrease of 21.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -81.41K → -804.78K (in $), with an average decrease of 888.5% per quarter
  • BNOX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 33.4% return, outperforming this stock by 113.7%
  • BNOX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 20.5% return, outperforming this stock by 118.6%
  • Price to Sales

    ForBNOX every $1 of sales, investors are willing to pay $3.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.5 for every $1 of sales.

Bionomics Financials in INR & Dollars

FY19Y/Y Change
Revenue
$3.6M
↓ 41.21%
Net Income
$-5.1M
↓ 60.66%
Net Profit Margin
-141.25%
↑ 69.88%
FY20Y/Y Change
Revenue
$1.4M
↓ 60.06%
Net Income
$-2.8M
↓ 45.01%
Net Profit Margin
-194.47%
↓ 53.22%
FY21Y/Y Change
Revenue
$531.5K
↓ 66.3%
Net Income
$-5.0M
↑ 62.39%
Net Profit Margin
-937.11%
↓ 742.64%
FY22Y/Y Change
Revenue
$2.9M
↑ 500.75%
Net Income
$-10.6M
↑ 130.36%
Net Profit Margin
-359.34%
↑ 577.77%
FY23Y/Y Change
Revenue
$290.7K
↓ 89.65%
Net Income
$-14.2M
↑ 41.19%
Net Profit Margin
-4.9K%
↓ 4543.17%
FY24Y/Y Change
Revenue
$20.0K
↓ 95.38%
Net Income
$-15.5B
↑ 72936.61%
Net Profit Margin
-77.5M%
↓ 7.745592749E7%
Q1 FY23Q/Q Change
Revenue
$172.6K
↑ 185.87%
Net Income
$-5.2M
↓ 29.13%
Net Profit Margin
-3.0K%
↑ 9180.4%
Q2 FY23Q/Q Change
Revenue
$31.3K
↓ 81.94%
Net Income
$-3.3M
↓ 36.83%
Net Profit Margin
-10.6K%
↓ 7561.32%
Q3 FY23Q/Q Change
Revenue
$172.8K
↑ 270.27%
Net Income
$-5.2M
↑ 5.83%
Net Profit Margin
-3.0K%
↑ 7561.31%
Q4 FY23Q/Q Change
Revenue
$98.9K
↓ 42.73%
Net Income
$-10.5M
↑ 100.37%
Net Profit Margin
-10.6K%
↓ 7561.33%
Q3 FY24Q/Q Change
Revenue
$98.9K
-
Net Income
$-804.8K
↑ 888.46%
Net Profit Margin
-813.44%
-
FY19Y/Y Change
Profit
$-2.3M
↓ 66.18%
FY20Y/Y Change
Profit
$-1.3M
↓ 41.51%
FY21Y/Y Change
Profit
$-2.8M
↑ 85.24%
FY22Y/Y Change
Profit
$-4.8M
↑ 89.39%
FY23Y/Y Change
Profit
$-8.5M
↑ 83.98%
FY24Y/Y Change
Profit
$-434.4K
↓ 96.56%
Q1 FY23Q/Q Change
Profit
$-2.8M
↓ 42.39%
Q2 FY23Q/Q Change
Profit
$-1.6M
↓ 41.51%
Q3 FY23Q/Q Change
Profit
$-2.8M
↑ 14.3%
Q4 FY23Q/Q Change
Profit
$-5.2M
↑ 85.51%
Q2 FY24Q/Q Change
Profit
$-436.3K
↓ 91.56%
Q3 FY24Q/Q Change
Profit
$-5.2M
↑ 1084.7%
FY19Y/Y Change
Operating Cash Flow
$-7.6M
↓ 27.74%
Investing Cash Flow
$137.3K
↑ 143.28%
Financing Cash Flow
$2.1M
↑ 56.71%
FY20Y/Y Change
Operating Cash Flow
$-2.7M
↓ 64.32%
Investing Cash Flow
$-134.6K
↓ 198.72%
Financing Cash Flow
$-3.7M
↓ 275.33%
FY21Y/Y Change
Operating Cash Flow
$-5.8M
↑ 93.14%
Investing Cash Flow
$-61.3K
↓ 58.9%
Financing Cash Flow
$24.1M
↓ 689.02%
FY22Y/Y Change
Operating Cash Flow
$-10.6M
↑ 99.24%
Investing Cash Flow
$437.0K
↓ 875.13%
Financing Cash Flow
$13.1M
↓ 40.93%
FY23Y/Y Change
Operating Cash Flow
$-9.5M
↓ 5.36%
Investing Cash Flow
$322.1K
↓ 22.87%
Financing Cash Flow
$2.5M
↓ 80.14%
Q1 FY23Q/Q Change
Operating Cash Flow
$-435.5K
↓ 89.37%
Investing Cash Flow
$96.3K
↑ 50.93%
Financing Cash Flow
$-204.4K
↓ 107.55%
Q2 FY23Q/Q Change
Operating Cash Flow
$-3.1M
↑ 605.27%
Investing Cash Flow
$96.9K
↑ 0.0%
Financing Cash Flow
$2.4M
↓ 1263.52%

Bionomics Technicals Summary

Sell

Neutral

Buy

Bionomics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Bionomics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Bionomics Ltd
-11.41%
-67.84%
-80.91%
-97.98%
-98.3%
Regeneron Pharmaceuticals, Inc.
-4.72%
-33.43%
-16.35%
14.7%
89.27%
Biontech Se
9.01%
28.55%
5.71%
-57.13%
220.59%
Alnylam Pharmaceuticals, Inc.
-3.99%
7.16%
25.05%
27.48%
103.59%
Vertex Pharmaceuticals Incorporated
-12.1%
-16.49%
-2.12%
78.05%
80.31%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Bionomics Ltd
NA
NA
NA
0.0
-0.78
-0.4
NA
1.32
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.05
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Bionomics Ltd
Buy
$5.1M
-98.3%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
89.27%
17.67
33.61%
Biontech Se
Buy
$26.8B
220.59%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.7B
103.59%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$115.2B
80.31%
32.84
-4.51%

About Bionomics

bionomics is a biopharmaceutical company dedicated to making better treatments for cancer, central nervous system disorders such as anxiety, depression and alzheimer's disease. our exceptionally talented team is driven by a shared commitment to make a difference in diseases with inadequate treatment options. we are in a strong growth phase with our world-class portfolio of promising drug candidates from early to advanced stages of clinical development. this portfolio is fed by highly productive drug discovery platforms which includes multicore®, our proprietary chemistry capability. at the core of our business is strategic partnering. we partner with large pharmaceutical companies to get our drugs through the later stages of development and into the market as rapidly as possible. this means we can focus our strengths in innovative drug discovery to extract as many "shots on goal"​ from our diverse pipeline in the quest to create the world's new blockbuster drugs. we have a passion for
Organization
Bionomics
Employees
8
CEO
Dr. Spyridon Papapetropoulos M.D., Ph.D.
Industry
Miscellaneous

Management People of Bionomics

NameTitle
Dr. Spyridon Papapetropoulos M.D., Ph.D.
CEO, President & Director
Mr. Timothy M. Cunningham CPA, M.B.A.
Chief Financial Officer
Ms. Elizabeth Doolin
Senior Vice President of Clinical Development
Dr. Julie Kerner Ph.D.
Senior Vice President of Business Operations
Dr. Mark A. Smith M.D., Ph.D.
Chief Medical Officer
Mr. Adrian Hinton BEC, F.C.A.
Financial Controller

Important FAQs about investing in Bionomics from India :

What is Bionomics share price today?

Bionomics share price today stands at $0.24, Open: $0.25 ; Previous Close: $0.25 ; High: $0.27 ; Low: $0.23 ; 52 Week High: $1.60 ; 52 Week Low: $0.18. The stock opens at $0.25, after a previous close of $0.25. The stock reached a daily high of $0.27 and a low of $0.23, with a 52-week high of $1.60 and a 52-week low of $0.18.

Can Indians buy Bionomics shares?

Yes, Indians can invest in the Bionomics (BNOX) from India.

With INDmoney, you can buy Bionomics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Bionomics at zero transaction cost.

How can I buy Bionomics shares from India?

It is very easy to buy Bionomics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bionomics be purchased?

Yes, you can buy fractional shares of Bionomics with INDmoney app.

What are the documents required to start investing in Bionomics stocks?

To start investing in Bionomics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Bionomics

Today’s highest price of Bionomics (BNOX) is $0.27.

Today’s lowest price of Bionomics (BNOX) is $0.23.

What is today's market capitalisation of Bionomics

Today's market capitalisation of Bionomics BNOX is 5.1M

What is the 52 Week High and Low Range of Bionomics

  • 52 Week High

    $1.60

  • 52 Week Low

    $0.18

What are the historical returns of Bionomics?

  • 1 Month Returns

    -11.41%

  • 3 Months Returns

    -67.84%

  • 1 Year Returns

    -80.91%

  • 5 Years Returns

    -98.3%

Who is the Chief Executive Officer (CEO) of Bionomics

Dr. Spyridon Papapetropoulos M.D., Ph.D. is the current Chief Executive Officer (CEO) of Bionomics.